Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Financial Calendar

Half year report 2010: September 10, 2010

Annual Shareholders' meeting:  Milan, April 1, 2010

Publication of Annual Report 2009: March 3, 2010

Press and Analyst Conference: Zurich, March 3, 2010